Fenofibrate may reduce the risk of diabetic retinopathyBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7628.1017-a (Published 15 November 2007) Cite this as: BMJ 2007;335:1017
The lipid lowering agent fenofibrate could be useful for treating diabetic retinopathy if findings from a recent clinical trial are confirmed. Nearly 10 000 patients with type 2 diabetes took fenofibrate or a placebo for five years in addition to their usual …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial